531 related articles for article (PubMed ID: 36682072)
1. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings.
Karageorgiou V; Tyrrell J; Mckinley TJ; Bowden J
Genet Epidemiol; 2023 Mar; 47(2):135-151. PubMed ID: 36682072
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
Bowden J; Davey Smith G; Burgess S
Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
[TBL] [Abstract][Full Text] [Related]
3. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
Rees JMB; Wood AM; Burgess S
Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
[TBL] [Abstract][Full Text] [Related]
4. Impact of nonrandom selection mechanisms on the causal effect estimation for two-sample Mendelian randomization methods.
Yu Y; Hou L; Shi X; Sun X; Liu X; Yu Y; Yuan Z; Li H; Xue F
PLoS Genet; 2022 Mar; 18(3):e1010107. PubMed ID: 35298462
[TBL] [Abstract][Full Text] [Related]
5. Extending Causality Tests with Genetic Instruments: An Integration of Mendelian Randomization with the Classical Twin Design.
Minică CC; Dolan CV; Boomsma DI; de Geus E; Neale MC
Behav Genet; 2018 Jul; 48(4):337-349. PubMed ID: 29882082
[TBL] [Abstract][Full Text] [Related]
6. Profile-likelihood Bayesian model averaging for two-sample summary data Mendelian randomization in the presence of horizontal pleiotropy.
Shapland CY; Zhao Q; Bowden J
Stat Med; 2022 Mar; 41(6):1100-1119. PubMed ID: 35060160
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization mixed-scale treatment effect robust identification and estimation for causal inference.
Liu Z; Ye T; Sun B; Schooling M; Tchetgen ET
Biometrics; 2023 Sep; 79(3):2208-2219. PubMed ID: 35950778
[TBL] [Abstract][Full Text] [Related]
8. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.
Bowden J; Del Greco M F; Minelli C; Davey Smith G; Sheehan NA; Thompson JR
Int J Epidemiol; 2016 Dec; 45(6):1961-1974. PubMed ID: 27616674
[TBL] [Abstract][Full Text] [Related]
9. Mendelian randomization for causal inference accounting for pleiotropy and sample structure using genome-wide summary statistics.
Hu X; Zhao J; Lin Z; Wang Y; Peng H; Zhao H; Wan X; Yang C
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2106858119. PubMed ID: 35787050
[TBL] [Abstract][Full Text] [Related]
10. Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess S; Thompson SG
Eur J Epidemiol; 2017 May; 32(5):377-389. PubMed ID: 28527048
[TBL] [Abstract][Full Text] [Related]
11. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.
Hartwig FP; Davey Smith G; Bowden J
Int J Epidemiol; 2017 Dec; 46(6):1985-1998. PubMed ID: 29040600
[TBL] [Abstract][Full Text] [Related]
12. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.
Bowden J; Davey Smith G; Haycock PC; Burgess S
Genet Epidemiol; 2016 May; 40(4):304-14. PubMed ID: 27061298
[TBL] [Abstract][Full Text] [Related]
13. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
Ward-Caviness CK; de Vries PS; Wiggins KL; Huffman JE; Yanek LR; Bielak LF; Giulianini F; Guo X; Kleber ME; Kacprowski T; Groß S; Petersman A; Davey Smith G; Hartwig FP; Bowden J; Hemani G; Müller-Nuraysid M; Strauch K; Koenig W; Waldenberger M; Meitinger T; Pankratz N; Boerwinkle E; Tang W; Fu YP; Johnson AD; Song C; de Maat MPM; Uitterlinden AG; Franco OH; Brody JA; McKnight B; Chen YI; Psaty BM; Mathias RA; Becker DM; Peyser PA; Smith JA; Bielinski SJ; Ridker PM; Taylor KD; Yao J; Tracy R; Delgado G; Trompet S; Sattar N; Jukema JW; Becker LC; Kardia SLR; Rotter JI; März W; Dörr M; Chasman DI; Dehghan A; O'Donnell CJ; Smith NL; Peters A; Morrison AC
PLoS One; 2019; 14(5):e0216222. PubMed ID: 31075152
[TBL] [Abstract][Full Text] [Related]
14. MRCIP: a robust Mendelian randomization method accounting for correlated and idiosyncratic pleiotropy.
Xu S; Fung WK; Liu Z
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33704372
[TBL] [Abstract][Full Text] [Related]
15. Weak-instrument robust tests in two-sample summary-data Mendelian randomization.
Wang S; Kang H
Biometrics; 2022 Dec; 78(4):1699-1713. PubMed ID: 34213007
[TBL] [Abstract][Full Text] [Related]
16. Robust inference of bi-directional causal relationships in presence of correlated pleiotropy with GWAS summary data.
Xue H; Pan W
PLoS Genet; 2022 May; 18(5):e1010205. PubMed ID: 35576237
[TBL] [Abstract][Full Text] [Related]
17. The use of two-sample methods for Mendelian randomization analyses on single large datasets.
Minelli C; Del Greco M F; van der Plaat DA; Bowden J; Sheehan NA; Thompson J
Int J Epidemiol; 2021 Nov; 50(5):1651-1659. PubMed ID: 33899104
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropy-robust Mendelian randomization.
van Kippersluis H; Rietveld CA
Int J Epidemiol; 2018 Aug; 47(4):1279-1288. PubMed ID: 28338774
[TBL] [Abstract][Full Text] [Related]
19. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
Front Immunol; 2022; 13():956005. PubMed ID: 36159838
[TBL] [Abstract][Full Text] [Related]
20. An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting.
Grant AJ; Burgess S
Biostatistics; 2022 Apr; 23(2):609-625. PubMed ID: 33155035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
